ReAl-woRld evaluation of tEzepelumab for chronic rhinoSinusitis with nasal polyps in Russia

Trial Identifier:	D5242R00010
Sponsor:	AstraZeneca
Start Date:	December 2025
Primary Completion Date:	March 2028
Study Completion Date:	March 2028
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Russia	Ekaterinburg, Russia
Russia	Kazan, Russia
Russia	Moscow, Russia
Russia	Ryazan, Russia
Russia	Saint-Petesburg, Russia

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.